Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 5 | 8 | 15 | 18 | 17 |
| Gross Profit | 5 | 8 | 15 | 18 | 17 |
| Operating Expenses | 4,014 | 3,697 | 3,570 | 15,073 | 878 |
| Operating Income | -4,009 | -3,689 | -3,555 | -15,055 | -861 |
| Interest Expense | 631 | 496 | 507 | 182 | 1,287 |
| Other Income | -15,763 | 0 | 0 | -417 | -3,613 |
| Pre-tax Income | -20,403 | -4,184 | -4,063 | -15,653 | -5,761 |
| Net Income Continuous | -20,403 | -4,184 | -4,063 | -15,653 | -5,761 |
| Net Income | $-20,403 | $-4,184 | $-4,063 | $-15,653 | $-5,761 |
| EPS Basic Total Ops | -5.77 | -4.99 | -5.10 | -21.44 | 6.87 |
| EPS Basic Continuous Ops | -5.76 | -4.99 | -5.10 | -21.44 | -6.26 |
| EPS Diluted Total Ops | -5.77 | -4.99 | -5.10 | -21.44 | 6.87 |
| EPS Diluted Continuous Ops | -5.76 | -4.99 | -5.10 | -21.44 | -6.26 |
| EBITDA(a) | $-3,923 | $-3,341 | $-3,208 | $-14,613 | $-624 |